companyprofile

Actions

National Medical Care Co.

4005
CARE
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close 201.00
  • Open 203.00
  • High 209.40
  • Low 201.00
  • No. of Trades 849
  • Avg. Trade size* 53
  • Volume Traded 44,966
  • Value Traded (SAR) 9,245,580.40

Performance

CARE
5.60 ( 2.79% )
Compare
Name Price Change %
National Medical Care Co. 203.00 2.79%
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
206.60
% Change
2.79
Volume Traded
52

Best Bid

Price 205.20
Volume 1

Best Offer

Price 206.60
Volume 561

52 WEEK

High
224.00
2024/02/20
Low
109.60
2023/08/08
Change**
60.65

PERFORMANCE

Start of Year
182
Year ago
128.6
3 Years ago
65

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Addendum Announcement from National Medical Care Co. in regards to results of the Extraordinary General Assembly Meeting, ( First Meeting )

    4005
    CARE 2.79 %
    1445/11/15     23/05/2024 16:00:48
  • National Medical Care Co. Announces the Results of the Extraordinary General Assembly Meeting, ( First Meeting )

    4005
    CARE 2.79 %
    1445/11/15     23/05/2024 08:02:55
  • The National Medical Care Company Announces hosting Earnings Conference Call Q1,2024

    4005
    CARE 2.79 %
    1445/11/04     12/05/2024 15:36:32
  • National Medical Care Company announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months )

    4005
    CARE 2.79 %
    1445/11/04     12/05/2024 08:17:21
  • National Medical Care Co. announces to Invites its Shareholders to Attend the (First Meeting) Extraordinary General Assembly Meeting through the modern technology means

    4005
    CARE 2.79 %
    1445/10/20     29/04/2024 15:54:15
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      22/04/2024 22/05/2024 12/06/2024 Account Transfer 2.00
      21/03/2023 19/06/2023 10/07/2023 Account Transfer 1.00
      19/04/2022 17/05/2022 31/05/2022 Account Transfer 1.00
      28/03/2021 27/05/2021 16/06/2021 Account Transfer 1.00
      26/01/2020 15/04/2020 23/04/2020 Account Transfer 2.00

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet 2023-12-31
      Total Assets
      2,214,365
      - - -
      Total Liabilities
      760,929
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      1,453,436
      - - -
      Total Liabilities and Shareholders Equity
      2,214,365
      - - -
      Statement of Income 2023-12-31
      Total Revenue (Sales/Operating)
      1,081,783
      - - -
      Net Profit (Loss) before Zakat and Tax
      264,595
      - - -
      Zakat and Income Tax
      -23,667
      - - -
      Net Profit (Loss) after Zakat and Tax
      240,927
      - - -
      Total Comprehensive Income
      234,697
      - - -
      Profit (Loss) per Share
      5.37
      - - -
      Cash Flow 2023-12-31
      Net Cash From Operating Activities
      466,737
      - - -
      Net Cash From Investing Activities
      -624,941
      - - -
      Net Cash From Financing Activities
      137,661
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      329,213
      - - -
      Cash and Cash Equivalents, End of the Period
      308,670
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-02-27

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet 2024-03-31 2023-09-30
      Total Assets
      2,231,628
      1,910,928
      Total Liabilities
      696,905
      514,744
      Total Shareholders Equity (After Deducting the Minority Equity)
      1,534,724
      1,396,184
      Total Liabilities and Shareholders Equity
      2,231,628
      1,910,928
      Statement of Income 2024-03-31 2023-09-30
      Total Revenue (Sales/Operating)
      298,561
      275,359
      Net Profit (Loss) before Zakat and Tax
      74,361
      81,657
      Zakat and Income Tax
      6,927
      -8,276
      Net Profit (Loss) after Zakat and Tax
      81,287
      73,381
      Total Comprehensive Income
      81,287
      73,381
      Profit (Loss) per Share
      1.81
      1.64
      Cash Flow 2024-03-31 2023-09-30
      Net Cash From Operating Activities
      46,435
      484,263
      Net Cash From Investing Activities
      -168,338
      -505,953
      Net Cash From Financing Activities
      -5,673
      -37,552
      Cash and Cash Equivalents, Beginning of the Period
      308,670
      329,213
      Cash and Cash Equivalents, End of the Period
      181,095
      269,972
      All Figures in Thousands Thousands
      All Currency In SAR SAR
      Last Update Date 2024-05-12 2023-11-05

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-06-23 بشار عبدالعزيز صالح اباالخيل Board of Directors 0.0111483% 0.0111483% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      National Medical Care Co.
      Price 206.60
      Market Cap (SAR MN) 8,943
      P/E Ratio 33.63
      Index Name Index Level 1D Return
      National Medical Care Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      The activity of the company is in establishing, owning, equipping, maintaining and operating hospitals, health centers and units, providing healthcare services in all fields, any services and businesses that may cooperate in accomplishing its purposes, and owning lands and properties for the benefit of the Company.

      Company History

      The National Medical Care Co. was established in 2003 as a Closed Joint-Stock Company owned by the General Organization for Social Insurance (GOSI) and a group of shareholders. In 2013, it became a publicly Joint-Stock Company registered on the Saudi Stock Exchange (Tadawul). The Company currently owns several hospitals, including Riyadh Care Hospital, which has been renamed as Care Medical Alrawabi, formerly, known as the (Social Insurance Hospital) founded in 1990, which has 325 beds. The Company also owns National Care Hospital, which has been renamed as Care Medical Almalaz, founder in 1966, which has 459 beds. In addition, there is the Care Medical Alharam, which was opened in 2023. It is an emergency center located near the Holy Mosque in Mecca, providing emergency services for critical cases of pilgrims and visitors to the Holly Mosque, and Umrah performers. It has 54 beds. Lastly, there is the Care Medical AlBalad in Jeddah, specializing in long-term care, having 164 beds.

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 448,500,000
      • Issued Shares 44,850,000
      • Paid Capital (SAR) 448,500,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :-

      Investment limits

      There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and instructions for the Foreign Strategic Investors Ownership in listed companies based on company's bylaw and the issued instructions by the related regulators and supervisory authorities.

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        -

      • Financial Year End

        31/12

      • Listing Date

        /

      • External Auditors

        [PWC]

      • ISIN CODE

        SA139051UIH0

      • Number of Employees

        -

      • Chairman

        Saad Abdulmohsen Alfadly
        Non - Executive

        Saad Abdulmohsen Alfadly
        • BD Session Start
          2022-09-15
          Designation
          Chairman
        • BD Session End
          2025-09-14
          Classification
          Non - Executive
        Companies Membership
        • Memebrship Name
          SABB
          Start Date
          2020-01-01
        • Memebrship Character
          Non-Executive
          End Date
          2022-12-31
      • Board of Directors

        Michael Davis Deputy Chairman - Non Executive

        Michael Davis
        • BD Session Start
          2022-09-15
          Designation
          Board of Directors
        • BD Session End
          2025-09-14
          Classification
          Deputy Chairman - Non Executive

        Faraj Saad Al-Gabani Non - Executive

        Faraj Saad Al-Gabani
        • BD Session Start
          2022-09-15
          Designation
          Board of Directors
        • BD Session End
          2025-09-14
          Classification
          Non - Executive

        Bader Fahad AlAthel Non - Executive

        Bader Fahad AlAthel
        • BD Session Start
          2022-09-15
          Designation
          Board of Directors
        • BD Session End
          2025-09-14
          Classification
          Non - Executive

        May Mohammed Al-Hoshan Independent

        May Mohammed Al-Hoshan
        • BD Session Start
          2022-09-15
          Designation
          Board of Directors
        • BD Session End
          2025-09-14
          Classification
          Independent
        Companies Membership
        • Memebrship Name
          Alamar Foods Co
          Start Date
          2020-02-08
        • Memebrship Character
          Non - Executive
          End Date
          2023-02-07

        Sami Suliman Alkhashan Independent

        Sami Suliman Alkhashan
        • BD Session Start
          2022-09-15
          Designation
          Board of Directors
        • BD Session End
          2025-09-14
          Classification
          Independent

        Bashar Abdulaziz Abalkhail Independent

        Bashar Abdulaziz Abalkhail
        • BD Session Start
          2022-09-15
          Designation
          Board of Directors
        • BD Session End
          2025-09-14
          Classification
          Independent
        Companies Membership
        • Memebrship Name
          Saudi Paper Manufacturing Co
          Start Date
          2021-04-27
        • Memebrship Character
          Independent
          End Date
          2024-06-30
        • Memebrship Name
          Development Works Food Co
          Start Date
          2021-12-21
        • Memebrship Character
          Independent
          End Date
          2024-10-29

        Ahmed Wazaa Alqahtani Non - Executive

        Ahmed Wazaa Alqahtani
        • BD Session Start
          2022-09-15
          Designation
          Board of Directors
        • BD Session End
          2025-09-14
          Classification
          Non - Executive
        Companies Membership
        • Memebrship Name
          Savola Group
          Start Date
          2022-07-01
        • Memebrship Character
          Non-Executive
          End Date
          2025-06-30

        Abdulaziz Saleh AlObaid Executive

        Abdulaziz Saleh AlObaid
        • BD Session Start
          2022-09-15
          Designation
          Board of Directors
        • BD Session End
          2025-09-14
          Classification
          Executive
      • Senior Executives

        Abdulaziz Saleh Al-Obaid CEO

        Abdulaziz Saleh Al-Obaid
        • BD Session Start
          2019-01-01
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO

        Jahanzeb Ahmed Khan CFO

      Jahanzeb Ahmed Khan
      • BD Session Start
        2018-10-07
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Governance & Compliance Department

      Company Address:

      Al Imam Ahmad Ibn hanbal St. Ar Rayyan Area P.O. Box 29393 Riyadh 11457

      Contact Details:

      Telephone: 00966114931881
      Fax : -
      Email : care.ir@care.med.sa

      Company Website:

      www.care.med.sa


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.